Clinical Trials

116 enrolled

Infertility, Metabolic Diseases, Polycystic Ovary Syndrome

NCT05701527 2026-02-05

A Study of EBC-129 in Advanced Solid Tumours

98 enrolled

Other solid neoplasm

Advanced Solid Tumours

NCT04902313 2026-02-03

CROP

40 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT05308732 2026-01-08

Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

36 enrolled

Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT06546150 2025-12-16

RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid Tumors

KRAS G12D

NCT07139509 2025-11-25

UCAR-T_MM-XA

Plasma cell

Multiple Myeloma

NCT04812470 2025-09-22

HAITILS

8 enrolled

Uveal Melanoma, Melanoma

NCT07183852 2025-09-19

GoTIL-01

Uveal Melanoma, Melanoma

NCT07120607 2025-08-13

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Other hematologic neoplasm

9 enrolled

Leukemia

NCT04813653 2025-07-24

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

3 enrolled

Plasma cell

Multiple Myeloma

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

GastrointestinalGynecologicThoracic

20 enrolled

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT07034118 2025-06-24

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

23 enrolled

Esophageal Neoplasms

NCT03914443 2025-05-31

A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma

37 enrolled

Esophageal Squamous Cell Carcinoma

NCT05969314 2025-04-11

To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer

12 enrolled

BreastHead & Neck

Breast Neoplasms, Mouth Neoplasms

NCT04463368 2025-03-28

SCANDIUM II

Uveal Melanoma

NCT06846424 2025-02-26

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

24 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05917860 2025-02-17

NeoADT-TULSA

15 enrolled

Genitourinary

Prostatic Neoplasms

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

GastrointestinalGynecologicThoracic

90 enrolled

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT06758713 2025-01-06

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

LymphoidOther hematologic neoplasmPlasma cell

60 enrolled

Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms

NCT02521844 2024-10-08

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

89 enrolled

Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT06545201 2024-08-09

RE001 T Cell Injection for the Treatment of KRAS G12V Mutated Solid Tumors

KRAS G12V

NCT03245021 2024-07-30

1stFLOR

39 enrolled

Lymphoma, Follicular

NCT06415500 2024-05-16

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

9 enrolled

Gynecologic

Gynecologic Cancer

NCT05046665 2024-04-22

ZiPUP

11 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03610061 2024-04-12

RaDD

34 enrolled

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT06170463 2023-12-20

Insulin Sensitizers Role in Control of PCOS Vicious Cycle.

210 enrolled

Polycystic Ovary Syndrome

NCT05088889 2023-11-28

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Pancreatic Neoplasms

NCT04375267 2023-11-14

LuPARP

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT06056752 2023-10-24

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma

NCT05957939 2023-07-24

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

2 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05928962 2023-07-10

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Melanoma

NCT05927844 2023-07-03

XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma

20 enrolled

Esophageal Squamous Cell Carcinoma

NCT05903937 2023-06-15

HAITILS-PHP

6 enrolled

Uveal Melanoma, Melanoma

NCT05900089 2023-06-12

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Lymphoma, T-Cell, Peripheral

NCT05640713 2022-12-07

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

12 enrolled

Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited

NCT05561023 2022-09-30

Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain

14 enrolled

Hawthorn Red Combined Refractory Cancer Pain

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT05108012 2021-11-22

Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

5 enrolled

CNS

Glioblastoma

NCT04615312 2021-08-23

A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors

50 enrolled

Digestive System Tumors

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT03380689 2021-03-08

SIRB2

Phase 1 Withdrawn

Colorectal Neoplasms

NCT04270461 2020-10-22

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Phase 1 Withdrawn

CNSGastrointestinal

Colonic Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Medulloblastoma

NCT04326296 2020-05-15

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

33 enrolled

Colorectal Neoplasms

NCT03790228 2020-04-15

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

43 enrolled

Thoracic

Non-squamous Cell Non-Small Cell Lung Cancer

NCT04087252 2020-04-15

An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment

Tumor-Agnostic

Neoplasms

NCT03881761 2019-03-21

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

50 enrolled

Recurrence, Lymphoma, B-Cell

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

LymphoidOther hematologic neoplasm

20 enrolled

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03414450 2018-10-25

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Accelerated Phase

NCT03664661 2018-09-10

BCMA-CAR-T in Relapsed/Refractory Multiple Myeloma